Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (344)	6/17/1998 10:02:00 PM
From: Cacaito	Read Replies (1) of 1494

ncbi.nlm.nih.gov It is a good phase I study. Do you have the full article? The low blood pressure from crf could probably be overcome with steroids or other drugs. Is the low blood pressure clinically significant? Is the trauma patients phase II ongoing? It is a big market, peritumoral brain edema is much smaller. Still holding my shares, cacaito

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next